Investigating disparities in eye cancer treatment
Ocular melanoma is the most common form of eye cancer in adults. Though it's relatively rare, if left untreated, it can be lethal, spreading to other parts of the body. There are currently two main...
View ArticleStanford coach’s quest to save his brother: ‘God, I hope this works’
During a 2018 home game against Washington State University, David Shaw, Stanford's football coach, ambled slowly along the sideline, his joints aching. Wanting to focus on the players and the game,...
View ArticleClik here to view.
Stanford Medicine magazine’s top reads of 2020
How does a coronavirus infect a cell? What causes chemo brain? Why does epidemiologist Bonnie Maldonado, MD, love the 2011 film Contagion? You'll find answers to these questions and learn a lot about...
View ArticleClik here to view.
How a Nobel laureate’s life story and encouraging words inspire my scientific...
Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster for nearly ten hours. At 15, I was anxiously...
View ArticleEarlier colonoscopies halve subsequent cancer risk
"You're only as old as you feel" isn't really applicable to routine medical screening, I'm finding (somewhat ruefully). Lately it seems that each birthday comes with a new, ever-more-fun,...
View ArticleClik here to view.
Former patient writes book for kids on stem cell transplants
In 2015, when Rob Henslin stopped by Stanford Hospital to visit his former oncology nurses, he discovered they had a project in mind for him. They wanted him to write a book to help children...
View ArticleClik here to view.
Molecular clues could signal eye cancer survival odds
Stanford researchers have discovered that the level of certain proteins in the eye could predict survival risk in patients with uveal melanoma, a relatively rare but deadly form of adult eye cancer....
View ArticleWhy many stage 3 colorectal cancer patients skip chemo
Chemotherapy after stage 3 colorectal cancer surgery is effective and its side effects are usually limited, yet about a third of patients do not receive the treatment. To better understand why -- and...
View ArticleKeeping treatment-resistant skin cancer cells in check
Everybody loves a good origin story, right? In the most recent issue of Stanford Medicine magazine, I wrote about the career path of Stanford dermatologist Anthony Oro, MD, PhD, who, in the late...
View ArticleBlood test predicts chances of lymphoma relapse after therapy
Tools that track circulating tumor DNA, or ctDNA -- teeny fragments of genetic material released into the blood by dying cancer cells -- are giving doctors a clearer picture of which cancer patients...
View ArticleHow to beat cancer? Find the genes that help it hide
Even after decades of research, cancer cells still have secrets to spill. To that end, Stanford Medicine researchers have set out to discover the hidden drivers of cancer's insidious nature. In a...
View ArticleClik here to view.
Top 5 Scope stories of 2021
Unraveling the mysteries of COVID-19 and gritty stories of persistence in the face of pandemic peril took center stage this year on our Scope blog as we continued to share pandemic-themed stories of...
View ArticleStanford doctor helps pediatric cancer patients evacuate Ukraine
An academic pediatrician rarely gets to jump into the fray when children are at risk in war zones. That's not the case for Stanford Health Policy's Paul Wise, MD, who recently returned from Poland,...
View ArticleRouting cancer cells to the right path may boost treatment
About 20 years ago, scientists developed a powerful antibody treatment that helps the immune system find and kill tumor cells in neuroblastoma, a cancer that affects very young children, nearly all...
View ArticleData science could help tailor cancer therapy
Cancer is a wily, complex disease. To have any chance of beating it, doctors need an arsenal of tools and medications at their disposal. Chemotherapy, radiation, surgery, anti-cancer drugs and an...
View ArticleBuilding a cancer community through BLACC
When she had breast cancer, Juanita Waugh discovered that there is a lot more to managing the disease than what happens in the doctor's office. She had to learn how to cope with unexpected side...
View ArticleComing full circle with extrachromosomal DNA, cancer and Ptolemy
Every once in a while a story just seems to write itself. That's what happened when I was working on my feature story about vicious DNA circles for the latest issue of Stanford Medicine magazine....
View ArticleMolecules, shmolecules. Why should you care?
Writing the lead story for Stanford Medicine magazine is a privilege and a responsibility. It's basically a giant fishhook to entice readers to gobble the rest of the issue (which, I will say, is...
View ArticleExploring the ordinary and extraordinary in end-of-life care, death
Samuel LeBaron, MD, PhD, is a family medicine specialist and Stanford Medicine professor emeritus who now faces the situation he guided patients through during his career: navigating terminal lung...
View ArticleClik here to view.
A 2022 recap: Most read, most viewed and most popular on social media
As 2022 comes to close, we're revisiting some of our most popular and well-liked stories -- from how scientists recommend you take care of your mental health to the fascinating (if modestly...
View Article
